You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors

 

Online download statistics by month:

Online download statistics by month: March 2017 to September 2024

AbstractFullPdf
Mar 2017592122
Apr 2017014981
May 2017012877
Jun 20175814988
Jul 2017959549
Aug 201711711945
Sep 201714614862
Oct 2017969849
Nov 2017919142
Dec 2017777747
Jan 2018878748
Feb 201810094141
Mar 201811612045
Apr 201818518636
May 201812512754
Jun 201812212431
Jul 201811511539
Aug 201812312348
Sep 201815315370
Oct 201816516548
Nov 201816316321
Dec 201826126139
Jan 201921521129
Feb 201919018939
Mar 201911311332
Apr 2019656331
May 2019585828
Jun 2019464618
Jul 2019495026
Aug 2019343412
Sep 2019505030
Oct 2019505125
Nov 2019444323
Dec 2019404021
Jan 2020363614
Feb 2020404015
Mar 2020323218
Apr 2020484852
May 2020424323
Jun 2020313016
Jul 2020464524
Aug 2020292619
Sep 2020343118
Oct 2020393325
Nov 2020292816
Dec 2020252410
Jan 202120178
Feb 2021222114
Mar 2021282112
Apr 2021231816
May 2021332813
Jun 202114149
Jul 2021211913
Aug 2021272417
Sep 2021212019
Oct 2021514725
Nov 2021343127
Dec 202131308
Jan 2022454311
Feb 2022242510
Mar 202220196
Apr 202217158
May 2022403813
Jun 2022323115
Jul 2022636115
Aug 2022605214
Sep 2022393715
Oct 2022272718
Nov 2022373510
Dec 202226255
Jan 2023343421
Feb 202342385
Mar 2023382916
Apr 2023161013
May 2023121014
Jun 202310107
Jul 2023151511
Aug 2023111016
Sep 202319189
Oct 2023706912
Nov 202329306
Dec 2023363515
Jan 202453396
Feb 202438349
Mar 2024252163
Apr 2024343321
May 202416159
Jun 2024221914
Jul 2024615927
Aug 2024202016
Sep 2024303015
Total517155042492